All filters
Videos
Management of toxicities from immunotherapy: an ESMO Clinical Practice Guideline - Caroline O'Leary, BA (Hons), MSc (LSE), MB BCh BAO (Hons), MRCPI
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Management of Toxicities from Immunotherapy: an ESMO Clinical Practice Guideline | Caroline O'Leary, BA (Hons), MSc (LSE), MB BCh BAO (Hons), MRCPI
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Videos
Therapeutic Drug Monitoring of Small Molecule Inhibitors in Patient with Lung Cancer: Ready for the Clinic?- Markus Jörger, MD, PhD, ClinPharm
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Therapeutic Drug Monitoring of Small Molecule Inhibitors in Patient with Lung Cancer: Ready for the Clinic? | Markus Jörger, MD, PhD, ClinPharm
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Videos
Drug-Drug Interactions between Small Molecule Inhibitors with Directly-Acting Oral Anti-coagulants (DOACs) in Patients with Lung Cancer. - Lorenz Van der Linden, PharmD, PhD
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Drug-Drug Interactions between Small Molecule Inhibitors with Directly-Acting Oral Anti-coagulants (DOACs) in Patients with Lung Cancer. | Lorenz Van der Linden, PharmD, PhD
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Harmonization of DDI Guidelines Among Different Regulatory Agencies: Challenges and Opportunities | Elin Lindhagen
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Harmonization of DDI Guidelines Among Different Regulatory Agencies | Elin Lindhagen
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
GSK - ViiV Healthcare | Jon Collins
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Shionogi Inc. | Simon Portsmouth
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Pharmacokinetics of Sofosbuvir-Based Direct Acting Antivirals for HCV in Pregnancy | Catherine Chappell
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Temporal Changes in Dolutegravir and Raltegravir Glucuronide Metabolite to Parent Ratios | Tim Cressey
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Tissue-Specific Pharmacology Knowledge and Knowledge Gaps | Charles Flexner
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
New(er) Antiretrovirals in Pregnancy and Breastfeeding | Catriona Waitt
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Management of Antiplatelet/DOAC DDIS (Pk/PD) - in Context of HIV, HCV, COVID Antiviral Therapy | Mike Emerson
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
A Year of CAB/RPV Use, What Have We Learned in the Real World | Emma Rubenstein
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Is TDM Still Needed / Useful ? | Nancy Sheehan
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Platelet Count to Spleen Diameter Ratio as a Predictor of Oesophageal Varices in Patients with Liver Cirrhosis at Muhimbili National Hospital Dar es Salaam, Tanzania
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Molecular Characterization of Hepatitis B Virus Infection in HIV Infected Adults On Antiretroviral Therapy in Nairobi, Kenya
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
A Hepatitis B Virus Dual Point-of-Care Test Strategy to Identify Treatment-Eligible Patients in Africa
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023